Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 1, 1998, Pages

  Bhuta, Tushar ^a   Ohlsson, Arne ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Chronic lung disease; Dexamethasone; Meta analysis; Prevention; Randomised controlled trials

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; LUNG SURFACTANT;

ARTICLE; BIRTH WEIGHT; CHILDHOOD MORTALITY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFANT; INFANT DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; NEWBORN; PERINATAL PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031826684     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.1.F26     Document Type: Article

References (43)

1. Hennes HM, Lee MB, Rimm AA, Shapiro DL. Surfactant replacement therapy in respiratory distress syndrome. Meta-analyses of clinical trials of single dose surfactant extract. Am J Dis Child 1991;145:102-4.
2. Merritt TA, Hallman M, Bloom BT et al. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986;315:785-90.
3. Kendig JW, Notter RH, Cox C, et al. Surfactant replacement therapy at birth. Final analyses of a clinical trial and comparisons with similar trials. Pediatrics 1988;82:756-62.
4. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-8.
5. Long W, Thompson T, Sundell H, et al. Effects of two doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700-1350 gram infants with respiratory distress syndrome. J Pediatr 1991;118:595-605.
6. The OSIRIS Collaborative group. Early versus delayed neonatal use of synthetic surfactant-the judgment of OSIRIS. Lancet 1992;340:1363-9.
7. Jobe AH, Mitchell BR, Gunkel JH. Beneficial 7effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993;168:508-13.
8. Ohlsson A, Calvert SA, Hosking M, Shennan AT. Randomised controlled trial of dexamethasone treatment in very-low-birth-weigh infants with ventilator-dependent chronic lung disease. Acta Paediatr 1992;81:751-6.
9. Mammel MC, Johnson DE, Green TP, Thompson TR. Controlled trial of dexamethasone in infants with bronchopulmonary dysplasia. Lancer 1983;i:1356-8
10. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respiratory-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-11.
11. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator-and oxygen-dependent infants: A controlled trial. J Pediatr 1989;115:979-83.
12. Collaborative Dexamethasone Trial group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 1991,88:421-7.
13. Kramer LJ, Hultzen C. The role of steroids in early bronchopulmonary dysplasia. Pediatr Res 1978; 12:564A.
14. Merritt TA, Stuard ID, Puccia J, et al. Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 1981;98:949-56.
15. Ogden B, Murphy S, Saunders G, Pathak D, Johnson J. Neonatal lung neutrophils and lastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984;130:817-21.
16. McColm J, McIntosh N. Tracheal ILS as a predictor of chronic lung disease. Pediatr Res 1994;36:A153.
17. Groneck P, Opperman M, Speer CP. Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment. Pediatr Res 93;34:586-90.
18. Groneck P, Reuss D, Goetze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993;122:938-44.
19. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993;68:330-6.
20. Weichsel ME. The therapeutic use of glucocorticoid hormones in the perinatal period. Potential neurological hazards. Ann Neurol 1977;2:364-6.
21. Ng PC, Brownlee KG, Dear PR. Gastrointestinal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child 1991;66:1164-6.
22. Werner JC, Sicard RE, Hansen TWR, et al. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 1992;120:286-91.
23. Ehrenkranz RA. Steroids, chronic lung disease and retinopathy of prematurity. Pediatrics 1992;90:646-7.
24. Wilson DM, Baldwin RB, Ariagano RL. A randomised, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 1988;113:764-8.
25. Mukwaya G. Immunosuppressive effects and infections associated with corticosteroid therapy. J Pediatr Infect Dis 1988;7:499-504
26. Tan KL. Blood pressure in very low birthweight infants in the first 70 days of life. J Pediatr 1988;112:266-70.
27. Cochrane Library [ database on disc and CD-ROM ]. The Cochrane Collaboration. Oxford Update Software. London: BMJ Publishing Group. 1996.
28. Sinclair JC, Bracken MB eds. Effective Care of Newborn Infant. New York: Oxford University Press, 1992.
29. Schultz KF, Chalmers I, Haynes RJ, Altman DG. Empirical evidence of bias; dimensions of methodologic quality associated with estimates of treatment effect in controlled clinical trials. JAMA 1995;273:408-12.
30. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant treated infants. Pediatrics 1996;98:204-10.
31. Shinwell ES, Karplus M, Zmora E, et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child 1996;74:F33-7.
32. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Pediair Res 1994;36:122-8.
33. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome. A double blind, controlled study. J. Pediatr 1990;117:273-82.
34. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants. A randomised controlled trial. Pediatrics 1995; 95:584-90.
35. Brozanski BS, Jones JG, Gilmour CH, et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr 1995;126:769-76.
36. Kari MA, Ikonen RS, Koivisto M, Raivio KO. Dexamethasone treatment in preterm infants at risk of bronchopulmonary dysplasia. Arch Dis Child 1993;68:566-9.
37. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989;320:1505-10.
38. Yeh TF, Lin IJ, Sheih WS, et al. Prevention of chronic lung disease in premature RDS infants with early and prolonged dexamethasone therapy-a multicenter, double-blind controlled study. Pediatr Res 1994;36:262A.
39. Tapia JL, Ramirez R, Cifuentes J, et al. Effects of early dexamethasone administration on respiratory outcome in VLBW infants with respiratory distress syndrome treated with surfactant. Pediatr Res 1996;39:249A.
40. Gross SJ, Cummings JJ. Four year follow-up of a controlled trial of Dexamethasone in ventilator dependent preterm infants. Pediatr Res 1992;31:204A.
41. Fitzhardinge PM, Eisen A, Lejtenyi C, Metrakos K, Ramsay M. Sequelae of early steroid administration to the newborn infant. Pediatrics 1974;53:877-83.
42. Mammel MC, Fiterman C, Coleman M, Boros SJ. Short term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up. Dev Pharmacol Ther. 1987;10:1-11.
43. Ohlsson A. A randomised controlled trial of dexamethasone treatment in very low birth weight infants with ventilatory dependent chronic lung disease. [MSc thesis.] 1990: McMaster University, Canada.